Great Point Partners has acquired Lyocontract, a German pharmaceutical CDMO, to enhance its global capabilities and capitalize on the growing demand for contract manufacturing services.

Information on the Target

Founded in 2007, Lyocontract GmbH is a prominent independent contract development and manufacturing organization (CDMO) located in Ilsenberg, Germany. The company specializes in aseptic liquid filling, lyophilization, and packaging services for pharmaceuticals. With a state-of-the-art manufacturing facility that adheres to the European Union’s Annex 1 standards, Lyocontract excels in the production of liquid and freeze-dried parenteral drugs, distributing these products globally for both clinical and commercial purposes.

Industry Overview in Germany

Germany is one of the leading players in the global pharmaceutical manufacturing industry, renowned for its high standards in quality control and innovation. The nation’s pharmaceutical sector benefits from robust regulatory frameworks, fostering a conducive environment for business operations. With significant investments in research and development, Germany remains at the forefront of biopharmaceutical advancements, attracting numerous stakeholders in the healthcare landscape.

The demand for contract manufacturing organizations is on the rise, particularly for companies specializing in lyophilization services. As pharmaceutical companies endeavor to streamline their production processes and pivo